CALM1 and neoplasm: In conclusion, the combined effect of CALM1 and EGFR was observed to be able to remarkably inhibit tumor development in KYSE150 and Eca109 cells, suggesting that the combined effect of CALM1 and EGFR may assist in the development of new therapeutic strategies to enhance treatment efficacy of EGFR-targeted therapy.